MATTHEW RYDLEWSKI: Open Payments
NPI 1851915649 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 69 payments from 15 companies in 2025. Trend: 2023 $496 · 2024 $1,020 · 2025 $1,434
Food & beverage: $1,334Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $492 |
| UCB, Inc. | 10 | $221 |
| Lilly USA, LLC | 8 | $209 |
| ABBVIE INC. | 5 | $93 |
| PFIZER INC. | 3 | $61 |
| Amgen Inc. | 3 | $56 |
| LEO Pharma Inc. | 3 | $56 |
| Galderma Laboratories, L.P. | 3 | $47 |
| Organon LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
Products named: TREMFYA, Bimzelx, EBGLYSS, SKYRIZI, TALTZ, CIBINQO, OTEZLA, NEMLUVIO.
Industry payments across DE — which companies pay providers there.
